The decrease in breast-cancer incidence in 2003 in the United States.
暂无分享,去创建一个
Eric J Feuer | Kathleen A Cronin | Nadia Howlader | Donald A Berry | D. Berry | E. Feuer | N. Howlader | C. Berg | B. Edwards | R. Chlebowski | P. Ravdin | K. Cronin | Brenda K Edwards | Rowan T Chlebowski | Christine D Berg | Peter M Ravdin | C. Berg
[1] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[2] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.
[3] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[4] D. Miglioretti,et al. Hormone Therapy Prescribing Patterns in the United States , 2004, Obstetrics and gynecology.
[5] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[6] J. Selby,et al. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] 青儀 健二郎,et al. What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID: 15894097.--早期乳癌に対する化学療法・内分泌療法が乳癌再発・15年生存率に及 , 2006 .
[8] T. Powles,et al. Breast cancer response to hormone replacement therapy withdrawal , 1995, The Lancet.
[9] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[10] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[11] R. Stafford,et al. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.
[12] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[13] P. Porter,et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.
[14] Xiaocheng Wu,et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations , 2006, Cancer.
[15] N. Bundred,et al. Short‐term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma , 2003, Cancer.